Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tight glycaemic control and the risk of hypoglycaemia
2008-002711-41Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by University of Dundee. Primary endpoints: Incidence of hypoglycaemia and Prevalence of hypoglycaemia. Started Jul 2008; status: completed.
02
Drugs
insulin aspartinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2008-002711-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002711-41.